{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:24:28Z","timestamp":1786983868891,"version":"build-2736575974"},"reference-count":30,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T00:00:00Z","timestamp":1751414400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005668","name":"Foundation for Research Support of the Federal District","doi-asserted-by":"publisher","award":["00193-00000279\/2023-70"],"award-info":[{"award-number":["00193-00000279\/2023-70"]}],"id":[{"id":"10.13039\/501100005668","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Anais Brasileiros de Dermatologia"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.abd.2025.501165","type":"journal-article","created":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T23:43:32Z","timestamp":1754351012000},"page":"501165","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Evaluation of Tyrosine Kinase-2 (TYK2) signaling pathway gene expression and the presence of the single-nucleotide polymorphism rs12720356 in the peripheral blood of patients with severe psoriasis and loss of systemic treatment response"],"prefix":"10.1016","volume":"100","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1012-7529","authenticated-orcid":false,"given":"Paola Borges Eckstein","family":"Canabrava","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-5223-5561","authenticated-orcid":false,"given":"Roll Stanley","family":"Beauge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8831-9926","authenticated-orcid":false,"given":"Samir de Figueiredo","family":"Azouz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1989-7412","authenticated-orcid":false,"given":"Renata Velozo","family":"Timb\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8596-3372","authenticated-orcid":false,"given":"Luciana Pereira Freire","family":"Martins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1567-0288","authenticated-orcid":false,"given":"Bruna C\u00f4rtes","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0710-1106","authenticated-orcid":false,"given":"Naiara Daris dos","family":"Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7035-4352","authenticated-orcid":false,"given":"Marcella Palhano","family":"Medeiros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7347-8246","authenticated-orcid":false,"given":"Andr\u00e9a Monteiro","family":"de Ara\u00fajo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8485-2603","authenticated-orcid":false,"suffix":"J\u00fanior","given":"Agenor de Castro Moreira dos","family":"Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1788-9745","authenticated-orcid":false,"given":"Carla Nunes de","family":"Ara\u00fajo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1775-7176","authenticated-orcid":false,"given":"Ot\u00e1vio de Toledo","family":"N\u00f3brega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5759-2727","authenticated-orcid":false,"given":"Patr\u00edcia Shu","family":"Kurizky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8182-5121","authenticated-orcid":false,"given":"Licia Maria Henrique da","family":"Mota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3069-6884","authenticated-orcid":false,"given":"Ciro Martins","family":"Gomes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.abd.2025.501165_bib0005","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1001\/jama.2020.4006","article-title":"Pathophysiology, clinical presentation, and treatment of Psoriasis:a review","volume":"323","author":"Armstrong","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.abd.2025.501165_bib0010","doi-asserted-by":"crossref","first-page":"579","DOI":"10.3389\/fimmu.2018.00579","article-title":"Systemic inflammation and cardiovascular comorbidity in Psoriasis patients: causes and consequences","volume":"9","author":"Boehncke","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.abd.2025.501165_bib0015","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1038\/ng.694","article-title":"Genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1","volume":"42","author":"Strange","year":"2010","journal-title":"Nat Genet"},{"key":"10.1016\/j.abd.2025.501165_bib0020","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-25282-2","article-title":"The psoriasis-protective TYK2 I684S variant impairs IL-12 stimulated pSTAT4 response in skin-homing CD4+ and CD8+ memory T-cells","volume":"8","author":"Enerb\u00e4ck","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.abd.2025.501165_bib0025","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.ad.2012.11.006","article-title":"The pathogenesis and genetics of psoriasis","volume":"105","author":"Puig","year":"2014","journal-title":"Actas Dermosifiliogr"},{"key":"10.1016\/j.abd.2025.501165_bib0030","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23116130","article-title":"Transcriptional basis of psoriasis from large scale gene expression studies: The importance of moving towards a precision medicine approach","volume":"23","author":"Krishnan","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.abd.2025.501165_bib0035","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1093\/hmg\/ddab237","article-title":"A transcriptome-wide association study identifies novel susceptibility genes for psoriasis","volume":"31","author":"Zhu","year":"2021","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.abd.2025.501165_bib0040","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/978-1-4939-3652-6_3","article-title":"Introduction to the gene expression analysis","volume":"1434","author":"Segundo-Val","year":"2016","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.abd.2025.501165_bib0045","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.jid.2015.11.025","article-title":"One SNP at a Time: Moving beyond GWAS in psoriasis","volume":"136","author":"Ray-Jones","year":"2016","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.abd.2025.501165_bib0050","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/s41576-019-0127-1","article-title":"Benefits and limitations of genome-wide association studies","volume":"20","author":"Tam","year":"2019","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.abd.2025.501165_bib0055","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1111\/bjd.19039","article-title":"British association of dermatologists guidelines for biologic therapy for psoriasis 2020: a rapid update","volume":"183","author":"Smith","year":"2020","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.abd.2025.501165_bib0060","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/j.jaad.2018.11.057","article-title":"Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with biologics","volume":"80","author":"Menter","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.abd.2025.501165_bib0065","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1016\/j.jaad.2020.02.044","article-title":"Joint American academy of dermatology-national psoriasis foundation guidelines of care for the management of psoriasis with systemic nonbiologic therapies","volume":"82","author":"Menter","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.abd.2025.501165_bib0070","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1016\/j.jclinepi.2011.07.010","article-title":"Strengthening the reporting of observational studies in epidemiology-molecular epidemiology STROBE-ME: an extension of the STROBE statement","volume":"64","author":"Gallo","year":"2011","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.abd.2025.501165_bib0075","doi-asserted-by":"crossref","DOI":"10.1111\/sji.12846","article-title":"The CCL20 and CCR6 axis in psoriasis","volume":"91","author":"Furue","year":"2020","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.abd.2025.501165_bib0080","doi-asserted-by":"crossref","first-page":"807","DOI":"10.3390\/cells8080807","article-title":"Keratin 6, 16 and 17-Critical Barrier alarmin molecules in skin wounds and Psoriasis","volume":"8","author":"Zhang","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.abd.2025.501165_bib0085","article-title":"Angiogenesis in chronic inflammatory skin disorders","volume":"22","author":"Lee","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.abd.2025.501165_bib0090","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1111\/1346-8138.12632","article-title":"Increased serum C-reactive protein level in japanese patients of psoriasis with cardio- and cerebrovascular disease","volume":"41","author":"Takahashi","year":"2014","journal-title":"J Dermatol"},{"key":"10.1016\/j.abd.2025.501165_bib0095","doi-asserted-by":"crossref","DOI":"10.1590\/1678-4685-gmb-2020-0425","article-title":"Association of TYK2 polymorphisms with autoimmune diseases: A comprehensive and updated systematic review with meta-analysis","volume":"44","author":"Pellenz","year":"2021","journal-title":"Genet Mol Biol"},{"key":"10.1016\/j.abd.2025.501165_bib0100","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1016\/j.jaci.2021.11.001","article-title":"Molecular and clinical effects of selective tyrosine kinase 2 inhibition with deucravacitinib in psoriasis","volume":"149","author":"Catlett","year":"2022","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.abd.2025.501165_bib0105","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/JID.2015.378","article-title":"Molecular phenotyping small (Asian) versus large (Western) plaque psoriasis shows common activation of IL-17 pathway genes but different regulatory gene sets","volume":"136","author":"Kim","year":"2016","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.abd.2025.501165_bib0110","article-title":"Two common disease-associated TYK2 variants impact exon splicing and TYK2 dosage","volume":"15","author":"Li","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.abd.2025.501165_bib0115","doi-asserted-by":"crossref","first-page":"7539","DOI":"10.4049\/jimmunol.0902740","article-title":"Tyrosine kinase 2 plays critical roles in the pathogenic CD4 T cell responses for the development of experimental autoimmune encephalomyelitis","volume":"183","author":"Oyamada","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.abd.2025.501165_bib0120","doi-asserted-by":"crossref","first-page":"237","DOI":"10.5021\/ad.2009.21.3.237","article-title":"A global gene expression analysis of the peripheral blood mononuclear cells reveals the gene expression signature in psoriasis","volume":"21","author":"Lee","year":"2009","journal-title":"Ann Dermatol"},{"key":"10.1016\/j.abd.2025.501165_bib0125","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.4049\/jimmunol.1402307","article-title":"Chronic psoriatic skin inflammation leads to increased monocyte adhesion and aggregation","volume":"195","author":"Golden","year":"2015","journal-title":"J Immunol"},{"key":"10.1016\/j.abd.2025.501165_bib0130","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/S0140-6736(19)31773-8","article-title":"Guselkumab versus secukinumab for the treatment of moderate-to-severe psoriasis (ECLIPSE): results from a phase 3, randomised controlled trial","volume":"394","author":"Reich","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.abd.2025.501165_bib0135","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1007\/s13555-021-00679-6","article-title":"Efficacy of risankizumab versus secukinumab in patients with moderate-to-severe psoriasis: Subgroup analysis from the IMMerge study","volume":"12","author":"Crowley","year":"2022","journal-title":"Dermatol Ther (Heidelb)"},{"key":"10.1016\/j.abd.2025.501165_bib0140","doi-asserted-by":"crossref","first-page":"D977","DOI":"10.1093\/nar\/gkac1010","article-title":"The NHGRI-EBI GWAS catalog: knowledgebase and deposition resource","volume":"51","author":"Sollis","year":"2023","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.abd.2025.501165_bib0145","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.ygeno.2013.11.001","article-title":"Gene expression profile based classification models of psoriasis","volume":"103","author":"Guo","year":"2014","journal-title":"Genomics"},{"key":"10.1016\/j.abd.2025.501165_bib0150","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jaad.2022.08.061","article-title":"Deucravacitinib versus placebo and apremilast in moderate to severe plaque psoriasis: Efficacy and safety results from the 52-week, randomized, double-blinded, phase 3 program for evaluation of TYK2 inhibitor psoriasis second trial","volume":"88","author":"Strober","year":"2023","journal-title":"J Am Acad Dermatol"}],"container-title":["Anais Brasileiros de Dermatologia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0365059625001072?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0365059625001072?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T15:45:54Z","timestamp":1777563954000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0365059625001072"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S0365059625001072"],"URL":"https:\/\/doi.org\/10.1016\/j.abd.2025.501165","relation":{},"ISSN":["0365-0596"],"issn-type":[{"value":"0365-0596","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of Tyrosine Kinase-2 (TYK2) signaling pathway gene expression and the presence of the single-nucleotide polymorphism rs12720356 in the peripheral blood of patients with severe psoriasis and loss of systemic treatment response","name":"articletitle","label":"Article Title"},{"value":"Anais Brasileiros de Dermatologia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.abd.2025.501165","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Sociedade Brasileira de Dermatologia. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}],"article-number":"501165"}}